As an economic and financial center, Shanghai has outstanding advantages in integrated circuits, biomedicine and new materials. The introduction of this merger and reorganization plan highlights Shanghai's determination to actively develop new quality productive forces and achieve autonomy and control.The action plan proposes that by 2027, we will strive to land a number of representative M&A cases in key industries, and cultivate about 10 internationally competitive listed companies in key industries such as integrated circuits, biomedicine and new materials, forming a scale of M&A transactions of 300 billion yuan and activating total assets of over 2 trillion yuan; Gather 3-5 professional M&A fund managers with strong industry influence, and the M&A service ability of intermediaries has been greatly improved, and the M&A service platform has played an active role; The joint efforts of the city, urban areas, government and enterprises have been significantly strengthened, and the policy guarantee system has made concerted efforts to build Shanghai into a pioneering area and demonstration area for mergers and acquisitions of listed companies with significantly improved industrial level, more sound M&A ecology and diversified and long-term cooperation mechanism, so as to better serve the high-quality development of the economy.According to the key industrial fields mentioned in the action plan, Shanghai's local semiconductor leading enterprises, pharmaceutical leading enterprises and new material leading enterprises are also expected to benefit from the merger and acquisition plan.
Shanghai local hard technology stocks exposed.Among them, the market value of chip leader SMIC A shares exceeded 170 billion yuan, ranking first. According to the data, SMIC is one of the world's leading integrated circuit wafer foundry enterprises, and it is a professional wafer foundry enterprise with advanced technology, the largest scale, the most complete supporting services and transnational operation.According to the key industrial fields mentioned in the action plan, Shanghai's local semiconductor leading enterprises, pharmaceutical leading enterprises and new material leading enterprises are also expected to benefit from the merger and acquisition plan.
After-hours big profits are related to mergers and acquisitions, restructuring, Shanghai state-owned shares have these.It is worth mentioning that among the stocks with a market value of less than 10 billion yuan, Kaikai Industry, Fudan Fuhua, First Hospital and Xuantai Medicine all belong to the biomedical industry. Among the state-owned shares in Shanghai, Hua Hong Company and Hehui Optoelectronics -U belong to the semiconductor industry.Shanghai local hard technology stocks exposed.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14